Causal system modelling of cervical cancer screening.

[1]  H. Adami,et al.  International incidence rates of invasive cervical cancer before cytological screening , 1997 .

[2]  M. Plummer,et al.  Time since first sexual intercourse and the risk of cervical cancer , 2012, International journal of cancer.

[3]  S. Franceschi,et al.  Impact of variations in triage cytology interpretation on human papillomavirus-based cervical screening and implications for screening algorithms. , 2016, European journal of cancer.

[4]  M. Plummer,et al.  Infection transmission and chronic disease models in the study of infection-associated cancers , 2013, British Journal of Cancer.

[5]  M. Poljak,et al.  HPV-FASTER: broadening the scope for prevention of HPV-related cancer , 2016, Nature Reviews Clinical Oncology.

[6]  J. Lew,et al.  Primary HPV testing versus cytology-based cervical screening in women in Australia vaccinated for HPV and unvaccinated: effectiveness and economic assessment for the National Cervical Screening Program. , 2017, The Lancet. Public health.

[7]  Mark S Roberts,et al.  Causal system modeling in chronic disease epidemiology: a proposal. , 2007, Annals of epidemiology.

[8]  Clare Gilham,et al.  Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials , 2014, The Lancet.

[9]  S. Franceschi,et al.  Cervical cancer screening in women vaccinated against human papillomavirus infection: Recommendations from a consensus conference. , 2017, Preventive medicine.

[10]  Deborah Bateson,et al.  Assessment of herd immunity and cross-protection after a human papillomavirus vaccination programme in Australia: a repeat cross-sectional study. , 2014, The Lancet. Infectious diseases.